Iovance Biotherapeutics (IOVA)

Earnings in 2025 (TTM): -A$0.62 Billion

According to Iovance Biotherapeutics 's latest financial reports the company's current earnings are A$0.26 Billion. a decrease over its 2024 earnings that were of -A$0.56 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Iovance Biotherapeutics from 2008 to 2025

Annual earnings

Year	Earnings	Change
2025	-A$0.57 Billion	0.74%
2024	-A$0.56 Billion	-14.17%
2023	-A$0.66 Billion	15.46%
2022	-A$0.57 Billion	16.39%
2021	-A$0.49 Billion	30.83%
2020	-A$0.38 Billion	26.62%
2019	-A$0.3 Billion	61.29%
2018	-A$0.19 Billion	38.09%
2017	-A$0.14 Billion	73.16%
2016	-A$75.79 Million	92.7%
2015	-A$39.33 Million	131.17%
2014	-A$17.02 Million	-51.71%
2013	-A$35.24 Million	6291.81%
2012	-A$0.56 Million
2008	-A$0.09 Million

Earnings for similar companies or competitors

Company	Earnings	Earnings differencediff.	Country
Nymox Pharmaceutical NYMX	-A$3.06 Million	-99.46%	Bahamas
NRC Health NRC	A$38.95 M	-106.92%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Earnings for Iovance Biotherapeutics (IOVA)

Earnings in 2025 (TTM): -A$0.62 Billion